Broker rates these 2 top ASX 200 shares as buys in July

Hub24 and ResMed are among this broker's favourites.

| More on:
Person pressing the buy button on a smartphone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Brokers are always on the hunt for opportunities. Ord Minnett has picked out two ASX 200 share ideas
  • ResMed is one of the leading ASX healthcare shares. It aims to help patients with sleep apnea
  • Hub24 is one of Australia’s leading fintech companies

The S&P/ASX 200 Index (ASX: XJO) could be the place to look for shares that are leaders in their industry, while also being good value.

But which ASX shares should investors go for? The broker Ord Minnett has named some companies it thinks are opportunities to buy.

Recent volatility makes it tricky to know which shares are the best value. However, brokers like to name share price targets, which is their best guess about where a share price will be in 12 months.

While a share price target is certainly not a guarantee of returns, it can indicate how much potential an ASX share may have in the broker's eyes.

These two are rated as buys by Ord Minnett and seemingly have good upside potential.

ResMed Inc (ASX: RMD)

ResMed is an expert in helping people with sleep apnea. The company says it has innovative solutions that treat and keep people out of hospital, empowering them to live healthier, higher-quality lives.

It says it has digital health technologies and cloud-connected medical devices that can transform care for people with sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic diseases. It operates in more than 140 countries.

Ord Minnett recently focused on the news that the ASX 200 share will acquire Medifox Dan for approximately US$1 billion. This company specialises in software solutions for professional and non-professional care, therapeutic practices and child, family and youth welfare facilities. It also has digital solutions for modern training and education management.

Medifox Dan made pro forma net revenue of US$83 million in 2021, with pro forma adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) of approximately $35 million.

While Ord Minnett rates ResMed as a buy with a price target of $35, it thought the acquisition price was high considering what's going on globally with the decline of share prices.

At the time of writing, the ResMed share price is up 0.8% at $31.05.

Hub24 Ltd (ASX: HUB)

Hub24 is a platform business in the financial technology (fintech) world. It has different segments including Hub24, Xplore, HUBconnect and Class.

The company boasts that it is Australia's fastest-growing platform provider. Hub24's market share has grown to around 5%, with an ongoing strong share of net flows.

It aims to lead the wealth industry as the best provider of an integrated platform, technology and data solutions.

The ASX 200 share is growing quickly. In the quarter for the three months to 31 March 2022, it saw net inflows of $2.6 billion, which was an increase of 36.4% year on year. Total funds under administration (FUA) was $68.3 billion at 31 March 2022 – platform FUA of $51 billion was up 43.3% year on year.

The financials are showing rapid growth. FY22 first-half platform segment revenue rose 76% to $77.3 million, while underlying net profit after tax (NPAT) went up 103% to $14.2 million.

It's currently rated as a buy by Ord Minnett, with a price target of $30. The broker thinks Hub24 has an attractive long-term future and can continue to achieve attractive inflows.

The Hub24 share price is up 0.59% to $20.41 in early trading on Thursday.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Hub24 Ltd and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended Hub24 Ltd and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Best Shares

A family of four wearing Santa hats open presents on the beach next to a Christmas tree.
Opinions

Top ASX shares to buy before Christmas

Here are some guilt-free purchases that you can snag without battling a crowd this Christmas.

Read more »

Three young people lie in the surf on a beach wearing santa hats.
Growth Shares

3 ASX growth stocks I want in my Christmas stocking this year

I think these companies look set to back up a bumper 2024 with another great year in 2025.

Read more »

Six young people wearing Santa hats sit on a beach celebrating at sunset.
Best Shares

Top ASX shares to buy in December 2024

Our Foolish writers reckon these stocks make seriously sensible buying this silly season!

Read more »

Three shareholders climbing ladders up into the clouds
Share Gainers

11 ASX All Ords shares rising faster than Nvidia over the past year

Who knew? Here are the homegrown ASX companies outperforming Nvidia on share price growth over the past 12 months.

Read more »

Three women cruise along enjoying ice-creams in the sunshine.
Best Shares

3 ASX 300 stocks up by more than 300% in a year

These stocks certainly add up to a triple treat.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Best Shares

Top ASX shares to buy with $500 in November 2024

$500 worth of ASX shares might not sound like a huge investment. But, to realise the benefits of compounding, you…

Read more »

asx share price boosted by us investment represented by hand waving US flag across winning athlete
Best Shares

Here are the best-performing ASX 200 shares since the US election result

We reveal the 10 ASX stocks that have had the highest share price gains since the US Presidential election.

Read more »

A smiling man at a shop counter takes payment from a female customer, with racks of plants in the background.
Best Shares

Here's why I think Wesfarmers shares are a great buy for any ASX investor

I argue that Wesfarmers offers investors both growth and income potential.

Read more »